<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01087359</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2010-010</org_study_id>
    <nct_id>NCT01087359</nct_id>
  </id_info>
  <brief_title>Antiinflammatoric and Antioxidative Effect of Melatonin in Human Endotoxaemia</brief_title>
  <official_title>Antiinflammatoric and Antioxidative Effect of Melatonin in Human Endotoxaemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Herlev Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Herlev Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double blinded, randomised, crossover study with 12 healthy men between 18 and 40
      year. The design is based on 6 days:

        -  day 1: On day time administration of LPS.

        -  day 2: On night time administration of LPS.

        -  day 3: On day time administration of LPS + Placebo.

        -  day 4: On day time administration of LPS + melatonin.

        -  day 5: On night time administration of LPS + placebo.

        -  day 6: On night time administration og LPS + melatonin.

      Measuring the inflammatoric and oxidative response of LPS and the effect of melatonin
      compared to placebo on the endotoxaemia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Inflammatoric markers</measure>
    <time_frame>measured before and after the administration of LPS endotoxin.</time_frame>
    <description>IL-6 TNF-alpha YKL-40</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxidative markers</measure>
    <time_frame>measured before and after the administration of LPS endotoxin.</time_frame>
    <description>Vit C MDA (malondialdehyde)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary outcome</measure>
    <time_frame>constant measurment</time_frame>
    <description>Holter Fatigue Karolinska Sleepness scale Blood pressure Heart rate Temperature</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Human Endotoxaemia</condition>
  <arm_group>
    <arm_group_label>LPS + melatonin night</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>LPS + placebo night</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>LPS + melatonin day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>LPS + placebo day</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>LPS night</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>LPS day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin</intervention_name>
    <description>100 mg melatonin is tested on human endotoxaemia administrated on night and day time compared to placebo</description>
    <arm_group_label>LPS + melatonin night</arm_group_label>
    <arm_group_label>LPS + placebo night</arm_group_label>
    <arm_group_label>LPS + melatonin day</arm_group_label>
    <arm_group_label>LPS + placebo day</arm_group_label>
    <arm_group_label>LPS night</arm_group_label>
    <arm_group_label>LPS day</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men

          -  Age 18-49 year.

          -  Healthy

          -  No sleepiness disorders.

          -  No medication

          -  ASA I

        Exclusion Criteria:

          -  Allergia to melatonin

          -  Women

          -  Smoking.

          -  Alcohol abuse.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2010</study_first_submitted>
  <study_first_submitted_qc>March 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2010</study_first_posted>
  <last_update_submitted>June 17, 2011</last_update_submitted>
  <last_update_submitted_qc>June 17, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2011</last_update_posted>
  <responsible_party>
    <name_title>Mahdi Alamili</name_title>
    <organization>MA</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endotoxemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

